Introduction | My Story | My Labs | My Meds | My Advice |
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19 Sep 2021 | 19 | 0.89 | 4.3 | 12.1 H | 5.70 H | 16.4 | 40.1 | 260 | umc | UA Blood Large, RBC>50, Protein 30mg/dL | |||||||||||||
19 Sep 2021 | CT Abdomen/Pelvis wo IV Contrast, Trace caliectasis and pelviectasis of the left kidney. Trace left hydroureter. 6 mm stone left ureterovesicular junction. 3 mm stone midpole left kidney. No right kidney stone or hydronephrosis. 2.3 x 2.3 similar hypodense lesion upper pole right kidney. Punctate stone lower pole right kidney. No right hydronephrosis. Bladder wall thickness is within normal limits for this degree of distention. No bladder mass or bladder calculus is identified. | umc | |||||||||||||||||||||
12 Jun 2021 | 16 | 0.74 L | 4.1 | 6.9 | 5.42 | 15.9 | 46.2 | 214 | 160 | 51 | 95 | 75 | lca | HGB A1c 5.4; TSH 1.110; CRP 1; UA Occult Blood 1+, RBC >30, Bacteria few; UA Culture negative | |||||||||
27 Jan 2021 | 6 H | 140 | 14 | 3 | 15.0 | 165.4 | 90.7 | 19 | 0.83 | 4.3 | 8.1 | 5.69 | 16.5 | 49.9 | 237 | 163 | 60 | 87 | 85 | lca | HGB A1c 5.5; TSH 1.660; CRP 1; PSA 0.8; (DiaSorin) SAR-Cov-2 Antibody, IgG Positive | ||
17 Sep 2020 | 4 | 139 | 17 | 9 | 17.0 H | 153.5 | 110.7 | 14 | 0.83 | 4.3 | 7.7 | 5.48 | 16.1 | 47.4 | 237 | lca | Vitamin D, 25-OH 49.4; (DiaSorin) SAR-Cov-2 Antibody, IgG Positive | ||||||
13 Jan 2020 | 5 H | 120 | 18 | 6 | 18.5 H | 149.2 | 124.0 | 16 | 0.91 | 4.1 | 7.7 | 5.34 | 16.0 | 46.4 | 231 | lca | |||||||
08 Oct 2019 | 7 H | 126 | 16 | 3 | 8.1 | 75.9 | 106.7 | 14 | 0.79 | 3.9 | 7.1 | 5.35 | 15.7 | 45.9 | 224 | lca | Hemoglobin A1c 5.3; | ||||||
20 Feb 2019 | 5 H | 132 | 16 | 60+ | 2 | 16 | 0.87 | 4.3 | 6.4 | 5.50 | 16.0 | 46.8 | 202 | lca | TSH 1.660; Urine trace Protein, neg Occult Blood | ||||||||
18 Oct 2018 | 5 H | 128 | 17 | 60+ | 13 | 0.86 | 4.0 | 7.5 | 5.50 | 16.0 | 48.9 | 220 | 145 | 57 | 73 | 77 | lca | fasting; TSH 1.350; Vitamin D, 25-OH 40.4 | |||||
19 Sep 2017 | 6 H | 112 | 15 | 57 | 2 | 11.7 H | 70.3 H | 166.4 | 12 | 0.75 L | 4.1 | 6.0 | 5.46 | 16.1 | 47.2 | 198 | 151 | 59 | 76 | 82 | lca | fasting; TSH 2.370; T4 6.8; Vitamin D, 25-OH 43.4; UA: WBC 0-5, RBC none, Urobilinogen 0.2 | |
03 Oct 2016 | 393.3mg/24h H | 1.734g/24h | 226.8 | lca | 24hr Urine | ||||||||||||||||||
26 Jul 2016 | 462.5mg/24h H | 1.640g/24h | 282.0 | lca | 24hr Urine, vol=2,500ml | ||||||||||||||||||
19 Jul 2016 | 7 H | 113 | 13 L | 54 | 9 | 30.1 H | 141.1 | 213.3 | 13 | 0.73 L | 4.1 | 6.4 | 5.39 | 15.6 | 47.2 | 196 | 155 | 57 | 90 | 42 | lca | Vitamin D 25-OH 48.5; fasting; Urine trace Protein,neg Occult Blood, RBC 0-2 | |
15 Apr 2016 | 434.2mg/24h H | 1.641g/24h | 264.6 | lca | 24hr Urine, vol=2,600ml, no monoclonal proteins by protein electrophoresis | ||||||||||||||||||
13 Apr 2016 | 8 H | 129 | 18 | >60 L | 4 | 82.8 H | 244.8 | 338.2 | 15 | 0.81 | 4.3 | 7.0 | 5.62 | 16.3 | 48.3 | 216 | 165 | 61 | 87 | 87 | lca | Vitamin D, 25 OH, D3 45.3; fasting; Urine +2 Protein,+1 Occult Blood, RBC 3-10, abnormal APTT, DRVVT Ratio, Hexagonal Phospholipid Neutral | |
07 Mar 2016 | 433.2mg/24h H | 1.725g/24h | 251.1 | lca | 24hr Urine, vol=1,900ml, Creatinine 0.908g/L, Protein 228mg/L (30-150) | ||||||||||||||||||
01 Feb 2016 | 345.8mg/24H H | 1.477g/24h | 234.1 | lca | 24hr Urine, vol=1,400ml, Creatinine 1.055g/L, Protein 247mg/L (50-150) | ||||||||||||||||||
19 Jan 2016 | 8 H | 120 | 19 | >60 L | 2 | 42.4 H | 178.1 | 238.1 | 12 | 0.79 | 4.4 | 7.9 | 5.65 | 17.0 | 48.6 | 214 | 160 | 66 | 77 | 87 | lca | Vitamin D, 25 OH, D3 42.7; fasting; Urine +1 Protein, | |
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
19 Oct 2015 | 8 H | 135 | 16 | 55 | 2 | 33.6 H | 140.2 | 239.7 | 14 | 0.79 | 4.3 | 6.8 | 5.68 | 16.7 | 48.8 | 212 | 163 | 66 | 84 | 64 | lca | Vitamin D, 25 OH, D3 42.5; fasting; Urine +1 Protein, CRP 1.0 (ref 0.0-4.9) | |
25 Jun 2015 | 9 H | 127 | 17 | 61 | 4 | 19.0 H | 112.7 | 168.6 | 14 | 0.79 | 4.3 | 6.3 | 5.47 | 15.8 | 47.0 | 192 | 163 | 61 | 89 | 65 | lca | Vitamin D, 25 OH, D3 37.5; fasting; APTT 40.7 high, APTT 1:1 NP 38.9 high, Hexagonal Phospholipid Neutral 27 high, all other LAC normal; | |
06 Apr 2015 | 8 H | 135 | 18 | 57 | 5 | 12.7 | 84.2 | 150.8 | 16 | 0.78 | 4.2 | 7.3 | 5.50 | 15.6 | 46.6 | 216 | 162 | 61 | 85 | 81 | lca | Vitamin D, 25 OH, D3 36.5; fasting; CRP 1.9 (ref 0.0-4.9); APTT 43.7 high, APTT 1:1 NP 40.1 high, Hexagonal Phospholipid Neutral 24 high, all other LAC normal; | |
09 Mar 2015 | 9 H | 186 H | 26 | 63 H | 10 | 97.2 H | 225.3 | 431.4 | 14 | 0.73 L | 4.3 | 8.4 | 5.681 | 16.4 | 49.1 | 202 | 163 | 47 | 95 | 105 | lca | Vitamin D, 25 OH, D3 39.0; non-fasting; CRP 25.5 (ref 0.0-4.9); UA 10-30RBC, 2+ Prot, 3+ Blood, Calcium Oxalate; RNP, Sm, aSC-70, a-SS-A/B, aChromatin, a-Jo-1, a-Centromere B all neg.; Lyme neg.; APTT 48.6 high, APTT 1:1 NP 39.6 high, Hexagonal Phospholipid Neutral 21 high, all other LAC normal; | |
27 Oct 2014 | 8 H | 123 | 18 | 59 | 2 | 25.6 H | 158.9 | 161.1 | 19 | 0.77 | 4.2 | 6.8 | 5.41 | 15.6 | 46.7 | 190 | 154 | 60 | 82 | 62 | lca | Vitamin D, 25 OH, D3 33.9 | |
07 May 2014 | 66.20 H | 323 H | 205.0 | nyp | UA: 1+ Blood, 2+ Protein, RBC 4, Hyal Cast 3-5 | ||||||||||||||||||
28 Apr 2014 | 9 H | qdl | |||||||||||||||||||||
28 Apr 2014 | 8 H | 122 | 17 | 59 | 2 | 34.9 H | 137.4 | 254.0 | 14 | 0.68 L | 4.2 | 7.5 | 5.44 | 15.7 | 47.0 | 188 | lca | Vitamin D, 25 OH, D3 35.9 ; UA: 4-10 RBC | |||||
31 Dec 2013 | 17 | 0.77 | 4.3 | 6.70 | 5.48 | 16.10 | 47.70 | 207 | 167 | 59 | 91 | 83 | pmg | Vitamin D, 25 OH, D3 21 ng/mL | |||||||||
04 Nov 2013 | 9 H | 116 | 19 | 54 | 1 | 17.1 | 108 | 158.3 | 17 | 0.79 | 4.3 | 7.3 | 5.57 | 16.2 | 49.1 | 159 | qdl | ||||||
09 May 2013 | 11 H | 109 | 18 | 60 | 4 | 10.3 | 79 | 130.4 | 16 | 0.74 | 4.4 | 6.7 | 5.00 | 14.8 | 45.0 | 168 | qdl | ||||||
14 Feb 2013 | 11 H | 122 | 21 | 58 | 4 | 35.1mg H | 249 | 141.0 | 16 | 0.83 | 4.3 | 6.3 | 5.37 | 15.8 | 47.5 | 180 | qdl | ||||||
05 Nov 2012 | 10 H | 130 | 22 | 1 | 28.9 H | 172 | 168.0 | 16 | 0.72 | 4.4 | 6.6 | 5.35 | 16.1 | 48.8 | 201 | 151 | 63 | 78 | 52 | qdl | |||
30 Jul 2012 | 11 H | 138 | 24 | >60 L | 242mg/24h H | 2.17g/24h | 111.5 | 15 | 0.88 | 4.6 | 7.4 | 5.43 | 16.3 | 47.7 | 188 | qdl | 24hr Urine, vol=2,300ml, Creatinine 0.95g/L, Protein 105mg/L (50-250), Protein/Creatinine 111mg/g creat (<=84) | ||||||
02 May 2012 | 11 H | 125 | 23 | 56 | 4 | 34.9 H | 206 | 169.4 | 13 | 0.73 | 4.5 | 6.1 | 5.45 | 16.2 | 49.2 | 194 | 148 | 66 | 71 | 54 | qdl | Urine Protein 170mg/g creat (22-128),PTT-LA 46H Hexagonal Phase Confirm + | |
02 Apr 2012 | 14 H | 119 | 22 | 2 | 16 | 0.75 | 4.7 | 6.1 | 5.21 | 15.9 | 46.7 | 186 | qdl | Vitamin D total: 29L (30-100), PTT-LA 41H Hexagonal Phase Confirm + | |||||||||
01 Nov 2011 | 12 H | 141 | 26 | 12 | 0.73 L | 4.0 | 12.1 H | 4.89 | 14.9 | 42.7 | 213 | 140 | 50 | 75 | qdl | ADNA NOT RDL! | |||||||
14 Sep 2011 | 11.1 H | 162 H | 24 | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
14 Sep 2011 | 15 | 0.74 L | 4.3 | 6.3 | 5.14 | 15.4 | 42.7 | 183 | qdl | ||||||||||||||
03 May 2011 | 16 H | 160 | 26 | 19.0 | 140 | 135.7 | 15 | 0.75 L | 4.4 | 6.7 | 5.30 | 15.8 | 47.3 | 177 | 162 | 62 | 85 | qdl | ADNA NOT RDL! | ||||
11 Jan 2011 | Appendectcomy for appendicitis, CT Abdomen +, US Abdomen, DX Chest, EKG | pmc | |||||||||||||||||||||
01 Nov 2010 | 16 H | 138 | 25 | 60+ H | 14.7 | 118 | 124.6 | 12 | 0.73 L | 4.3 | 7.0 | 4.94 | 15.4 | 44.8 | 158 | qdl | ADNA NOT RDL! | ||||||
01 Nov 2010 | Cardiolipin ab IGA/G/M -, B2 Glycoprotein I ab IGM/G -, Lupus Anticoag -, PTT-LA 45H, DRVVT 24, Hexagonal Phase Confirm - | qdl | |||||||||||||||||||||
23 Aug 2010 | EKG | pmg | |||||||||||||||||||||
17 Aug 2010 | 16 | 0.77 L | 4.1 | 7.1 | 5.20 | 15.7 | 47.2 | 153 | 152 | 54 | 77 | qdl | |||||||||||
11 Aug 2010 | 12.3 H | 153 H | 23 | rdl | |||||||||||||||||||
11 Aug 2010 | 14 | 0.88 | 4.0 | 7.8 | 5.13 | 15.7 | 46.8 | 164 | qdl | ||||||||||||||
10 May 2010 | 14 H | 149 | 24 | 9.2 | 169 | 54.4 | 15 | 0.81 | 4.0 | 6.6 | 5.19 | 15.9 | 46.8 | 158 | 165 | 54 | 90 | qdl | ADNA NOT RDL! | ||||
21 Apr 2010 | CT IVP: Normal except "severe degenerative disc disease" at L5-S1. | prd | |||||||||||||||||||||
16 Mar 2010 | 15.4 H | 165 H | 23 | rdl | |||||||||||||||||||
16 Mar 2010 | 17 | 0.72 L | 4.1 | 8.0 | 5.27 | 15.9 | 47.4 | 175 | 150 | 50 | 80 | qdl | |||||||||||
19 Nov 2009 | Cystoscopy: Bladder changes consistent with previous Cytoxan use. | jdb | |||||||||||||||||||||
26 Oct 2009 | 17 | 0.73 L | 4.0 | 8.1 | 5.16 | 15.7 | 45.9 | 171 | 142 | 53 | 73 | qdl | |||||||||||
18 Aug 2009 | 17.4 H | 184 H | 28 | rdl | |||||||||||||||||||
18 Aug 2009 | 16 | 0.82 | 4.3 | 9.9 | 5.45 | 16.2 | 49.3 | 187 | 159 | 54 | 85 | qdl | |||||||||||
04 May 2009 | 18 H | 146 | 22 | 10.0 | 163 | 61.3 | 18 | 0.83 | 4.1 | 6.9 | 5.29 | 16.1 | 47.3 | 165 | qdl | ADNA NOT RDL! | |||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
05 Apr 2009 | Normal urine cytology. | qdl | |||||||||||||||||||||
20 Mar 2009 | Colonoscopy | rho | |||||||||||||||||||||
17 Feb 2009 | 16.3 H | 187 H | 23 | rdl | |||||||||||||||||||
17 Feb 2009 | 17 | 0.83 | 4.2 | 7.7 | 5.24 | 15.8 | 47.3 | 167 | qdl | ||||||||||||||
01 Dec 2008 | 20 H | 135 | 25 | 17.1 | 222 | 77.0 | 12 | 0.86 | 4.0 | 7.3 | 5.07 | 15.3 | 45.5 | 167 | 124 L | 49 | 57 | qdl | ADNA NOT RDL! | ||||
30 Sep 2008 | 17 | 0.84 | 4.1 | 6.2 | 5.14 | 15.6 | 46.4 | 161 | 183 | 50 | 112 | qdl | |||||||||||
23 Sep 2008 | Normal Cardiac Stress Echocardiography Test, Dr. A. Costin. Simvistatin changed from 20mg to 40mg? | pmg | |||||||||||||||||||||
19 Aug 2008 | 18 H | 147 | 20 | rdl | |||||||||||||||||||
17 Jun 2008 | 22 H | 150 | 24 | 6.4 | 102 | 62.7 | 16 | 0.85 | 4.2 | 7.6 | 5.30 | 15.7 | 48.8 | 167 | 155 | 50 | 83 | qdl | ADNA NOT RDL! | ||||
26 Feb 2008 | 19.2 H | 147 | 21 | rdl | |||||||||||||||||||
26 Feb 2008 | 16 | 0.83 | 4.2 | 7.1 | 5.07 | 15.7 | 46.2 | 182 | qdl | ADNA NOT RDL! | |||||||||||||
04 Dec 2007 | <30 | 146 | 21 | 10.3 | 179 | 57.5 | 18 | 0.82 | 3.9 | 7.7 | 5.04 | 15.8 | 45.6 | 177 | 163 | 45 | 94 | qdl | ADNA NOT RDL! | ||||
30 Aug 2007 | 20.1 H | 161 H | 22 | rdl | |||||||||||||||||||
30 Aug 2007 | 17 | 0.8 | 4.0 | 6.7 | 4.91 | 15.3 | 45.2 | 160 | qdl | ADNA NOT RDL! | |||||||||||||
25 Jul 2007 | <30 | 149 | 25 | 61 | qdl | ADNA NOT RDL! | |||||||||||||||||
31 May 2007 | 46 H | 140 | 24 | 60 | 1 | 15.3 | 349 | 43.8 | 15 | 0.8 | 4.2 | 7.1 | 5.29 | 16.3 | 48.5 | 155 | 181 | 46 | 112 | qdl | ADNA NOT RDL! | ||
31 May 2007 | Simvistatin chnaged from 10mg to 20mg. | .ev | |||||||||||||||||||||
27 Feb 2007 | 23.8 H | 149 | 21 | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
27 Feb 2007 | 16 | 0.8 | 4.1 | 8.1 | 5.19 | 15.8 | 47.0 | 178 | 188 | 44 | 115 | qdl | |||||||||||
28 Nov 2006 | 100 H | 140 | 22 | 60 | 1 | 14.3 | 235 | 60.9 | 16 | 0.9 | 4.1 | 5.9 | 5.49 | 17.3 H | 49.4 | 168 | qdl | ADNA NOT RDL! | |||||
28 Nov 2006 | ENA ab 1.44H, SCL-70 ab -, SS-A ab -, SS-b ab -, Cardiolipin ab IGA/G/M -, SM ab EIA -, SM/RNP ab 1.79H, Histone ab 2.4H, JO-1 ab 0.29- | qdl | |||||||||||||||||||||
22 Aug 2006 | 24.9 H | 144 | 23 | rdl | |||||||||||||||||||
22 Aug 2006 | 18 | 1.0 | 4.4 | qdl | |||||||||||||||||||
14 Jun 2006 | 56 H | 123 | 21 | 61 | 1 | 18.6 | 271 | 68.6 | 20 | 0.9 | 4.2 | 6.8 | 5.39 | 16.5 | 49.4 | 175 | qdl | ADNA NOT RDL! | |||||
25 Apr 2006 | 22.8 H | 141 | 23 | rdl | |||||||||||||||||||
25 Apr 2006 | 16 | 1.0 | 4.2 | 8.1 | 5.21 | 16.1 | 46.7 | 176 | qdl | ||||||||||||||
03 Jan 2006 | 65.4mg/24h | 1.73g/24h | 37.8 | qdl | 24hr Urine, vol=1,520ml | ||||||||||||||||||
14 Dec 2005 | 24.8 H | rdl | |||||||||||||||||||||
05 Dec 2005 | 66 H | 170 | 23 | 4 | 17 | 0.8 | 4.2 | 7.6 | 5.27 | 15.8 | 47.8 | 170 | qdl | ADNA NOT RDL! | |||||||||
27 Sep 2005 | 22.7 H | 129 | 17 | rdl | |||||||||||||||||||
06 Jul 2005 | 85 H | 58 | 1 | 68.9mg/24h | 2.05g/24h | 33.6 | 16 | 0.8 | 4.0 | 5.6 | 5.21 | 15.4 | 46.9 | 144 | qdl | ADNA NOT RDL!, 24hr urine, volumne=1,300ml | |||||||
28 Jun 2005 | 30.4 H | 130 | 21 | rdl | |||||||||||||||||||
26 Apr 2005 | 39 H | 60 H | 4 | 3.9 | 115 | 33.9 | 19 | 0.8 | 4.4 | 5.8 | 4.44 | 13.6 | 40.8 | 168 | qdl | ADNA NOT RDL! | |||||||
14 Mar 2005 | 49 H | 57 | 1 | 3.2 | 82 | 39.0 | 15 | 0.9 | 4.5 | 6.7 | 4.67 | 14.4 | 42.8 | 165 | qdl | ADNA NOT RDL! | |||||||
02 Mar 2005 | 29.7 H | 120 | 24 | rdl | |||||||||||||||||||
31 Jan 2005 | 61 H | 53 | 4 | 10.2 | 305 | 33.4 | 22 | 0.9 | 4.3 | 6.2 | 4.28 | 12.9 L | 39.2 | 155 | qdl | ADNA NOT RDL! | |||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
21 Dec 2004 | ACTH Stimulation Test: Normal Response, 17ug/dL Cortisol pre-ACTH, 22 ug/dL @ 30 minutes, 29 ug/dL @ 60 minutes | pmc | |||||||||||||||||||||
16 Dec 2004 | 60 H | 49 | 1 | 18 | 0.8 | 4.1 | 5.2 | 4.30 | 13.9 | 40.7 | 151 | qdl | ADNA NOT RDL! | ||||||||||
22 Oct 2004 | 91 H | 56 | 1 | 17 | 0.9 | 4.3 | 5.8 | 4.48 | 14.3 | 41.7 | 140 | qdl | ADNA NOT RDL! | ||||||||||
06 Oct 2004 | MRI brain w/wo contrast, Normal Examination. | pra | |||||||||||||||||||||
05 Oct 2004 | ACTH Stimulation Test: Normal Response, 12ug/dL Cortisol pre-ACTH, 19 ug/dL @ 30 minutes, 22 ug/dL @ 60 minutes | pmc | |||||||||||||||||||||
27 Sep 2004 | 25.8 H | 121 | 23 | rdl | |||||||||||||||||||
17 Sep 2004 | 94 H | 1 | 6.0 | 105 | 57.1 | 17 | 0.9 | 4.4 | 6.3 | 4.14 L | 13.2 | 39.0 | 145 | qdl | ADNA NOT RDL! | ||||||||
26 Jul 2004 | 154.6 H | 52 | 1 | 84.2mg/24h | 1.74g/24h | 48.4 | 22 | 0.9 | 4.0 | 6.4 | 4.07 L | 12.8 L | 38.4 L | 143 | qdl | ADNA NOT RDL! NEW CH50 REF RANGE (26-58)! 24hr Urine, vol=1,170ml | |||||||
12 Jul 2004 | 30.0 H | 103 | 20 | rdl | |||||||||||||||||||
07 Jun 2004 | 107 H | nyp | ADNA NOT RDL! | ||||||||||||||||||||
01 Jun 2004 | 82 H | 61 H | 1 | 22 | 0.8 | 4.4 | 5.5 | 4.41 | 13.8 | 41.8 | 155 | qdl | ADNA NOT RDL! NEW CH50 REF RANGE (26-58)! | ||||||||||
27 Apr 2004 | 27.5 H | 112 | 25 | rdl | |||||||||||||||||||
05 Apr 2004 | 74 H | 138 | 1 | 122.2mg/24h | 1.795g/24h | 68.1 | 22 | 0.8 | 4.2 | 9.3 | 4.10 L | 13.2 | 39.2 | 151 | qdl | ADNA NOT RDL! | |||||||
29 Feb 2004 | 15 | 0.9 | 3.6 | 8.17 | 3.75 L | 11.9 L | 36.5 L | 146 L | pmc | ||||||||||||||
10 Feb 2004 | 25.5 H | 115 | 24 | rdl | |||||||||||||||||||
10 Feb 2004 | 101 H | 138 | 1 | 10.0 L | 87 | 114.9 | 19 | 0.9 | 4.3 | 9.6 | 4.08 L | 13.5 | 39.7 | 167 | qdl | ADNA NOT RDL! | |||||||
29 Dec 2003 | 61 H | 137 | 1 | 9.0 | 98 | 91.8 | 18 | 0.9 | 4.5 | 7.9 | 4.05 L | 12.4 L | 39.3 | 169 | qdl | ADNA NOT RDL! | |||||||
09 Dec 2003 | 24.5 H | 98 | 21 | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
01 Dec 2003 | 109 H | 1 | 26 H | 0.9 | 4.3 | 4.5 | 3.77 L | 12.4 L | 37.6 L | 156 | qdl | ADNA NOT RDL! | |||||||||||
10 Nov 2003 | 128 H | 108 | 18 | 1 | 18 | 0.8 | 4.2 | 7.4 | 3.74 L | 12.4 L | 37.3 L | 152 | qdl | ADNA/C3/C4 NOT RDL! | |||||||||
29 Oct 2003 | 120 H | 1 | 33.0 H | 324 | 101.9 | 18 | 0.8 | 4.0 | 4.5 | 3.91 L | 12.9 L | 38.6 | 150 | qdl | ADNA NOT RDL! | ||||||||
07 Oct 2003 | 47.6 H | 94 | 18 | rdl | |||||||||||||||||||
09 Sep 2003 | 77 H | 102 | 17 | 117 | 25 | 0.9 | 3.9 | 4.4 | 3.82 L | 12.7 L | 38.4 L | 132 L | qdl | ADNA/C3/C4 NOT RDL! | |||||||||
12 Aug 2003 | 27.7 H | 87 | 17 | rdl | |||||||||||||||||||
12 Aug 2003 | 21 | 0.9 | 3.9 | 3.5 L | 3.77 L | 12.5 L | 37.9 L | 138 L | qdl | ||||||||||||||
14 Jul 2003 | 202.9mg/24h H | 2.001g/24h H | 101.4 | qdl | 24hr Urine vol=1,470ml, TSH=1.59, T4=8, T3=178 | ||||||||||||||||||
02 Jul 2003 | 33.3 H | 105 | 20 | rdl | |||||||||||||||||||
02 Jul 2003 | 102 | 17 | 53 | 24 | 0.9 | 4.4 | 7.8 | 4.13 L | 13.4 | 41.4 | 157 | qdl | |||||||||||
03 Jun 2003 | 48.9 H | 87 | 18 | rdl | |||||||||||||||||||
03 Jun 2003 | 288mg/24h H | 1.76g/24h | 163.6 | 20 | 0.9 | 4.1 | 6.0 | 3.90 L | 12.9 L | 38.0 L | 156 | qdl | 24hr Urine | ||||||||||
06 May 2003 | 41.1 H | 77 L | 13 L | rdl | |||||||||||||||||||
06 May 2003 | 21 | 0.9 | 7.4 | 3.87 L | 12.5 L | 37.3 L | 156 | qdl | |||||||||||||||
15 Apr 2003 | 304 H | 141 | 5.0 | 88 | 56.8 | nyp | |||||||||||||||||
14 Apr 2003 | 45.2 H | 99 | 18 | rdl | |||||||||||||||||||
24 Mar 2003 | 43 H | 109 | 19 | rdl | |||||||||||||||||||
24 Mar 2003 | 140mg/24h | 1.7g/24h | 82.4 | 21 | 1.0 | 8.7 | 4.03 L | 12.9 L | 38.0 L | 236 | qdl | 24hr Urine | |||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
06 Mar 2003 | 286 H | 126 | 5 | 22 H | 0.7 | 4.3 | 9.6 H | 4.27 L | 12.8 L | 41.6 | 223 | nyp | |||||||||||
27 Feb 2003 | 45.6 H | 92 | 15 L | rdl | |||||||||||||||||||
27 Feb 2003 | 24 | 0.8 | 3.8 | 7.7 | 3.80 L | 11.8 L | 34.9 L | 219 | qdl | ||||||||||||||
07 Feb 2003 | 675mg/24h H | 1.4g/24h | 482.1 | 29 H | 0.8 | 3.8 | 8.1 | 3.01 L | 11.5 L | 33.9 L | 275 | qdl | 24hr Urine | ||||||||||
30 Jan 2003 | 49.8 H | 92 | 19 | rdl | |||||||||||||||||||
30 Jan 2003 | 450 H | 99 | 22 H | 0.7 | 3.6 L | 7.3 | 37.2 L | 214 | nyp | ||||||||||||||
25 Jan 2003 | 200+ H | 73 | 15 | 18 | 0.7 | 3.1 L | 9.35 | 4.19 | 12.0 L | 40.3 | 221 | pmc | |||||||||||
20 Jan 2003 | 230 H | nyp | |||||||||||||||||||||
20 Jan 2003 | Discharged from Columbia Presbyterian Medical Center. | nyp | |||||||||||||||||||||
16 Jan 2003 | 522 H | 84 | 13 L | 123 | nyp | ||||||||||||||||||
09 Jan 2003 | 425 H | 80 L | 14 L | 69 | nyp | ||||||||||||||||||
30 Dec 2002 | 342 H | 90 | 16 | nyp | |||||||||||||||||||
23 Dec 2002 | 454 H | 45 L | 8 L | 92 | nyp | ||||||||||||||||||
15 Dec 2002 | 791 H | 49 L | 7 L | nyp | |||||||||||||||||||
14 Dec 2002 | 738 H | 36 L | 7 L | nyp | |||||||||||||||||||
13 Dec 2002 | 943 H | 34 L | 7 L | 9 L | nyp | ||||||||||||||||||
13 Dec 2002 | Admitted to Columbia Presbyterian Medical Center. | nyp | |||||||||||||||||||||
12 Dec 2002 | 5.2 | 4.19 L | 11.3 L | 37.0 L | 229 | pmg | |||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
06 Dec 2002 | 35 L | 6 L | 2556mg/24h H | 1.4g/24h | 1825.7 | 0.8 | qdl | 24hr Urine, vol=1800ml | |||||||||||||||
06 Dec 2002 | 8.2 | 3.46 L | 9.3 L | 30.4 L | 166 | pmg | |||||||||||||||||
29 Nov 2002 | 25 H | 0.8 | 2.3 L | 8.3 | 4.31 L | 11.4 L | 34.9 L | 116 L | pmg | ||||||||||||||
29 Nov 2002 | Cytoxan, 1100mg IV | pmg | |||||||||||||||||||||
25 Nov 2002 | 25 H | 0.8 | 2.3 L | 8.3 | 4.31 L | 11.4 L | 34.9 L | 116 L | pmg | ||||||||||||||
25 Nov 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
22 Nov 2002 | 1.3g/24h | qdl | 24hr Urine, vol=1525ml | ||||||||||||||||||||
22 Nov 2002 | 29 H | 0.9 | 2.5 L | 3.4 L | 4.31 L | 11.4 L | 34.9 L | 116 L | pmg | ||||||||||||||
20 Nov 2002 | 328.0 H | 30 L | 7 L | rdl | |||||||||||||||||||
19 Nov 2002 | MRI Brain w/wo Contrast showed white matter abnormalities new since 10/30/98. | hra | |||||||||||||||||||||
15 Nov 2002 | 1.5 L | 4.27 L | 11.1 L | 35.5 L | 116 L | pmg | |||||||||||||||||
08 Nov 2002 | 2.5 L | 4.29 L | 11.4 L | 34.9 L | 119 L | pmg | |||||||||||||||||
06 Nov 2002 | 3.8 L | 4.39 L | 11.5 L | 34.9 L | 138 L | pmg | |||||||||||||||||
02 Nov 2002 | Cytoxan, 1200(?)mg IV | pmg | |||||||||||||||||||||
01 Nov 2002 | 4.2 L | 4.36 L | 11.4 L | 12.7 L | 137 L | pmg | |||||||||||||||||
28 Oct 2002 | Returned from Disney World out of vacation time and with no sick time left. | bjb | |||||||||||||||||||||
22 Oct 2002 | Departed for Disney World (did not have 11/20 lab results yet) | bjb | |||||||||||||||||||||
21 Oct 2002 | 10904 H | 1 L | 45 H | 1:1280 H | 27 H | 3.3 L | nyp | ||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
17 Oct 2002 | 3033.6 H | 30 L | 7 L | rdl | |||||||||||||||||||
17 Oct 2002 | 27 H | 1.0 | 3.2 L | qdl | |||||||||||||||||||
14 Oct 2002 | 0.9 | qdl | |||||||||||||||||||||
08 Oct 2002 | 4.5 | 4.62 | 12.7 L | 39.6 L | 140 L | pmg | |||||||||||||||||
01 Oct 2002 | 4.3 L | 4.58 L | 12.5 L | 39.0 L | 149 L | pmg | |||||||||||||||||
27 Sep 2002 | 6.0 | 4.53 L | 12.3 L | 38.9 L | 154 | pmg | |||||||||||||||||
20 Sep 2002 | 5.4 | 4.80 | 13.0 L | 41.3 | 144 L | pmg | |||||||||||||||||
20 Sep 2002 | Cytoxan, 960mg IV | pmg | |||||||||||||||||||||
06 Sep 2002 | 5.0 | 4.77 | 13.0 L | 41.3 | 136 L | pmg | |||||||||||||||||
04 Sep 2002 | 2.9 L | 4.84 | 13.2 L | 41.7 | 118 L | pmg | |||||||||||||||||
31 Aug 2002 | 3.3 L | 4.75 | 13.0 L | 41.2 | 107 L | pmg | |||||||||||||||||
28 Aug 2002 | 3.6 L | 4.92 | 13.6 | 42.8 | 138 L | pmg | |||||||||||||||||
23 Aug 2002 | 3.4 L | 4.99 | 13.6 | 43.2 | 141 L | pmg | |||||||||||||||||
16 Aug 2002 | 5.0 | 4.95 | 13.7 | 44.3 | 158 | pmg | |||||||||||||||||
09 Aug 2002 | Cytoxan, 1200mg IV | pmg | |||||||||||||||||||||
05 Aug 2002 | 9.1 | 5.01 | 14.4 | 44.3 | 175 | pmg | |||||||||||||||||
17 Jul 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
17 Jul 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
08 Jul 2002 | 374.4 H | 64 L | 10 L | rdl | Full ANA-12, See below. | ||||||||||||||||||
08 Jul 2002 | ANA>1:2560/Homogenous | SCL-70 EIA:Weak+ / Immunodiffusion: Neg / Western Blot:+ | SM: Mod+ | RNP: Str+ | Chromatin: Str+ | rdl | Full RDL ANA-12 Panel | ||||||||||||||||||||
08 Jul 2002 | 1936mg/24h H | 1.6g/24h | 1210.0 | 6.0 | 4.68 | 13.4 | 40.6 | 187 | qdl | 24hr Urine, vol=1225ml; Retic. Count=0.8% | |||||||||||||
19 Jun 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
19 Jun 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
03 Jun 2002 | Switched CellCept from 1500mg 2x/day to 1000mg 3x/day | bjb | |||||||||||||||||||||
01 Jun 2002 | Increased CellCept from 1000mg/2x to 1500mg 2x/day | kpx | |||||||||||||||||||||
22 May 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
22 May 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
20 May 2002 | 94.0 H | 52 L | 6 L | rdl | |||||||||||||||||||
20 May 2002 | 24 | 0.9 | 3.9 | 5.0 | 4.43 | 12.5 L | 38.5 | 215 | qdl | ||||||||||||||
03 May 2002 | Echocardiogram, Normal | ake | |||||||||||||||||||||
24 Apr 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
22 Apr 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
19 Apr 2002 | Urine Analysis: RBC: 6, WBC: 8, Protein: 1+ | nyp | |||||||||||||||||||||
15 Apr 2002 | 1512mg/24h H | 2.0g/24h | 756.0 | qdl | 24hr Urine, vol=1200ml | ||||||||||||||||||
15 Apr 2002 | Chest X-Ray, Infiltrate in upper right lobe. | hra | |||||||||||||||||||||
25 Mar 2002 | 168.8 H | 49 L | 5 L | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
25 Mar 2002 | 26 H | 0.8 | 3.6 L | 8.6 | 4.82 | 13.7 | 41.7 | 219 | qdl | ||||||||||||||
20 Mar 2002 | pmg | ||||||||||||||||||||||
20 Mar 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
14 Mar 2002 | qdl | UA: Protein 2+ | |||||||||||||||||||||
20 Feb 2002 | 396.8 H | 51 L | 5 L | rdl | |||||||||||||||||||
20 Feb 2002 | 3 days in a row of 1g SoluMedrol. | pmg | |||||||||||||||||||||
20 Feb 2002 | 1000mg Solumedrol IV x 3 days | ake | |||||||||||||||||||||
28 Jan 2002 | 374.4 H | 54 L | 5 L | rdl | |||||||||||||||||||
28 Jan 2002 | 29 H | 1.0 | 4.1 | 4.4 | 4.54 | 13.3 | 38.7 | 191 | qdl | UA: Protein 1+, Amorphous Crystals, Mucus | |||||||||||||
26 Nov 2001 | 46.6 H | 85 | 13 L | rdl | |||||||||||||||||||
25 Sep 2001 | 128.5mg/24h | 1.874g/24h | 68.6 | qdl | 24hr Urine | ||||||||||||||||||
24 Sep 2001 | 33.5 H | 102 | 14 L | rdl | |||||||||||||||||||
13 Sep 2001 | 25 | 0.8 | 4.6 | 4.5 | 4.90 | 14.2 | 43.2 | 193 | qdl | ||||||||||||||
30 Jul 2001 | 33.2 H | 107 | 16 | rdl | |||||||||||||||||||
30 Jul 2001 | 11 | 24 | 0.8 | 4.7 | 4.9 | 4.89 | 14.4 | 43.1 | 212 | qdl | |||||||||||||
25 May 2001 | 41.8 H | 93 | 14 L | rdl | |||||||||||||||||||
24 May 2001 | 24 H | 0.8 | 4.3 | 6.3 | 4.72 | 14.1 | 41.3 | 200 | qdl | ||||||||||||||
12 Mar 2001 | 38.0 H | 90 | 14 L | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
18 Jan 2001 | 53.2 H | 93 | 15 L | rdl | |||||||||||||||||||
05 Dec 2000 | 8 | 192mg/24h H | 2.084g/24h H | 92.1 | 25 H | 0.8 | 6.1 | 4.63 | 13.9 | 41.3 | 200 | qdl | 24hr Urine, Reticulocyte Count: 1.18 (0.60-1.90) | ||||||||||
21 Nov 2000 | 74.5 H | 91 | 13 L | rdl | |||||||||||||||||||
26 Sep 2000 | 65.6 H | 98 | 13 L | rdl | |||||||||||||||||||
18 Sep 2000 | 220mg/24h H | 1.63g/24h | 135.0 | 22 | 0.8 | qdl | 24hr Urine | ||||||||||||||||
03 Aug 2000 | 93.2 H | 189 | 36 | 1:1280 H | rdl | See scan for ANA-12 panel | |||||||||||||||||
03 Aug 2000 | 67 | 5.6 | 4.51 | 13.7 | 39.8 | 210 | qdl | ||||||||||||||||
18 Jul 2000 | 117.6 H | 86 L | 11 L | rdl | |||||||||||||||||||
07 Jun 2000 | 23 H | 78 L | 11 L | rdl | |||||||||||||||||||
07 Jun 2000 | 5.2 | 4.33 | 12.9 | 37.6 | 185 | qdl | 5% of lymphocytes are atypical, Occasional large platelets, Slight Toxic Granulation | ||||||||||||||||
25 May 2000 | Increased CellCept to 500mg 3x day | kpx | |||||||||||||||||||||
23 May 2000 | 25 | 0.8 | 4.1 | 3.6 L | 4.41 | 13.3 L | 38.5 L | 171 | skb | 2 weeks after starting CellCept | |||||||||||||
09 May 2000 | Started 500mg CellCept 2x day | kpx | |||||||||||||||||||||
05 May 2000 | 520 H | 57 L | <10 L | 16 H | 5.2 | 4.62 | 13.4 | 40.8 | 153 L | nyp | |||||||||||||
11 Apr 2000 | 157.2 H | 82 L | 11 L | rdl | |||||||||||||||||||
11 Apr 2000 | 205.2mg/24h H | qdl | 24hr Urine | ||||||||||||||||||||
16 Mar 2000 | 19 | 0.8 | 3.8 | 7.1 | 4.29 L | 13.1 L | 38.6 L | 180 | skb | 13 days post-Cytoxan | |||||||||||||
03 Mar 2000 | 119.6 H | 102 | 13 L | rdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
03 Mar 2000 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
11 Feb 2000 | 12 | skb | Urinalysis showed no RBC and 0-5 WBC (normal) | ||||||||||||||||||||
20 Dec 1999 | 41.1 H | 97 | 14 L | rdl | |||||||||||||||||||
10 Dec 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
07 Oct 1999 | 5.0 | 4.21 L | 13.1 L | 38.5 L | 140 | skb | 13 days post-Cytoxan | ||||||||||||||||
04 Oct 1999 | 364mg/24h H | 1.7g/24h | 214.1 | 23 | 0.8 | skb | 24hr Urine | ||||||||||||||||
24 Sep 1999 | 39.6 H | 101 | 14 L | rdl | |||||||||||||||||||
24 Sep 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
22 Sep 1999 | APTT: 27.3 [28.6-45.6], Lupus Anticoagulant: 1.03 [<1.30], Vitamin B12: 299 [200-950], RPR: Non-Reactive | nyp | |||||||||||||||||||||
14 Sep 1999 | Beta-2 Glycoprotein, IGA < 21, IGG < 21, IGM < 21 | skb | |||||||||||||||||||||
23 Aug 1999 | 37 | 92 | 16 | 141 | 8 | 1:1280 H | 19 | 0.7 | 4.6 | 5.4 | 4.70 | 14.4 | 42.7 | 220 | nyp | Positive Anti-Cardiolipin Antibodies | |||||||
16 Aug 1999 | 355mg/24h H | 1.7g/24h | 208.8 | skb | 24hr Urine | ||||||||||||||||||
16 Aug 1999 | Chest X-Ray, Normal | prh | |||||||||||||||||||||
16 Aug 1999 | 14 H | 1:1280 H | 4.2 | 2.78 L | 5.09 | 15.4 | 46.1 | 135 L | pmc | ||||||||||||||
09 Aug 1999 | 3.6 L | skb | 10 days post-Cytoxan | ||||||||||||||||||||
30 Jul 1999 | 46.2 H | 119 | 15 L | rdl | |||||||||||||||||||
30 Jul 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
18 Jun 1999 | 19 | 1.1 | 4.0 | 5.3 | 4.89 | 15.1 | 44.7 | 172 | skb | 14 days post-Cytoxan | |||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
04 Jun 1999 | 46.7 H | 119 | 17 | rdl | |||||||||||||||||||
04 Jun 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
21 May 1999 | Retina photos and Single Field Analyses | pec | |||||||||||||||||||||
19 Apr 1999 | 599mg/24hr H | 16 | 0.9 | 4.1 | 5.6 | 4.97 | 15.1 | 44.5 | 152 | skb | 24hr Urine 13 days post-Cytoxan | ||||||||||||
06 Apr 1999 | 24.4 H | 109 | 17 | rdl | |||||||||||||||||||
06 Apr 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
23 Mar 1999 | 5.1 | 4.96 | 15.0 | 44.2 | 155 | skb | 11 days post-Cytoxan | ||||||||||||||||
12 Mar 1999 | 29.1 H | 107 | 19 L | rdl | |||||||||||||||||||
12 Mar 1999 | 21 | 0.90 | 4.0 | 5.1 | 5.01 | 15.2 | 44.1 | qdl | |||||||||||||||
12 Mar 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
22 Feb 1999 | 5.7 | 4.92 | 14.9 | 43.5 | 173 | skb | 10 days post-Cytoxan | ||||||||||||||||
12 Feb 1999 | 24.6 H | 105 | 19 L | rdl | |||||||||||||||||||
12 Feb 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
22 Jan 1999 | 476mg/24h H | 1.7g/24h | 280.0 | skb | 24hr Urine | ||||||||||||||||||
21 Jan 1999 | Bone Density Analysis (DEXA), Osteopenia in left hip and right forearm. | hra | |||||||||||||||||||||
20 Jan 1999 | 13 | 0.8 | 4.0 | 6.0 | 4.68 | 14.1 | 41.1 | 170 | skb | 8 days post-Cytoxan | |||||||||||||
12 Jan 1999 | 29.2 H | 107 | 23 | rdl | |||||||||||||||||||
12 Jan 1999 | 16 | 0.80 | 4.20 | qdl | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
12 Jan 1999 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
15 Dec 1998 | 36.7 H | 92 L | 22 | rdl | |||||||||||||||||||
15 Dec 1998 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
16 Nov 1998 | 58.8 H | 86 L | 19 L | 1:2560 H | rdl | See scan for full lupus panel | |||||||||||||||||
16 Nov 1998 | Cytoxan, 1200mg IV | kpx | |||||||||||||||||||||
03 Nov 1998 | Lumbar Puncture | prh | |||||||||||||||||||||
31 Oct 1998 | Chest X-Ray, Normal | prh | |||||||||||||||||||||
30 Oct 1998 | CAR-MRI BRAIN WWO CNTRST-PRF, Normal Examination. | hra | |||||||||||||||||||||
11 Mar 1998 | 1432.2mg/24h H | 1.7g/24h | 842.5 | lca | 24hr Urine | ||||||||||||||||||
06 Mar 1998 | 44 L | 11 L | 3 | 16 | 0.8 | 4.3 | 4.2 | 4.69 | 14.5 | 43.7 | 177 | skb | |||||||||||
16 Feb 1998 | Kidney Biopsy, diffuse proliferative glomerulonephritis, class IV lupus nephritis, Chronicity: 2/12, Activity 12/24 | udl | |||||||||||||||||||||
02 Feb 1998 | 631 H | 50 L | 8 L | 18 | 0.8 | 4.2 | 5.1 | 4.61 | 14.3 | 41.3 | 172 | lca | |||||||||||
06 Jan 1998 | 359 H | 48 L | 3.2 L | 4.47 | 13.7 | 40.7 | 146 | lca | |||||||||||||||
01 Dec 1997 | 1573mg/24h H | .8 | pmc | 24hr Urine | |||||||||||||||||||
25 Aug 1997 | 924mg/24h H | 1.7g/24h | 543.5 | 0.9 | skb | 24hr Urine | |||||||||||||||||
22 Aug 1997 | 1:160 H | 54 L | 5.1 | 4.46 | 14.0 | 40.2 | 159 | qdl | |||||||||||||||
16 Dec 1996 | 588g/24h H | 0.7 | pmc | 24hr Urine | |||||||||||||||||||
11 Dec 1995 | 823mg/24h H | 0.6 | pmc | 24hr Urine | |||||||||||||||||||
Date Reverse Sort | ADNA | C3 | C4 | CH50 | Sed Rate | ANA | Protein (urine) | Creatinine (urine) | UPCR | BUN | Creatinine | Albumin | WBC | RBC | HGB | HCT | Platlets | Cholesterol | HDL | LDL | Trigs | Provider | Comment |
24 Nov 1995 | MRI brain, Normal study. | shb | |||||||||||||||||||||
23 Nov 1995 | Chest X-Ray, Normal | shb | |||||||||||||||||||||
12 Dec 1994 | Abdomenal CT scan, somewhat prominent spleen, 13cm in AP x 12cm in cc x 4.5cm in thickness | prh |
ake | Dr. Amy Etzweiler | c_m | Dr. Charles Martinson
gsw | Dr. Gail S. Williams
| hra | Hillsborough Radiology Associates, LLC
| jdb | John D. Birkoff
| jpm | Dr. J. P. Mohr
| kpx | Dr. Gilbert Kepecs
| lca | LabCorp
| nyp | NewYork-Presbyterian Hospital
| p_c | Dr. Paul LaCava
| pec | Princeton Eye Care Associates
| pmc | University Medical Center at Princeton Laboratories
| pra | Princeton Radiology Associates, P.A.
| prd | Princeton Radiology Associates, P.A.
| prh | Medical Center At Princeton, Department of Radiology
| qdl | Quest Diagnostics Incorporated
| rdl | Rheumatology Diagnostics Laboratory, Inc.
| rsb | Dr. Ralph S. Blume
| skb | SmithKline Beecham Clinical Laboratories
| udl | University Diagnostic Laboratories
| |